Literature DB >> 6327399

Differential antigen presentation in tumor immunity.

S Schatten, J A Drebin, R D Granstein, M I Greene.   

Abstract

The tumor S1509a elicits a cell-mediated immune response in immune A/J mice but leads to the generation of suppressor T cells (Ts) in nonimmune mice. Previous studies have shown that I-A+ antigen-presenting cells (APC) present S1509a tumor antigen and thereby activate immune T cells. Recent studies with polyoma-induced tumors reveal similar findings. Administration of anti-I-A antibodies not only prevents effective T cell activation by I-A+ APC bearing S1509a tumor antigen but also induces Ts after a tumor challenge. Ts, which inhibit S1509a tumor immunity, may be activated by tumor antigen presented on I-J+ APC. Examination of the immunologic effects of cyclophosphamide and UV radiation supports this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327399

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  3 in total

1.  IA mutation affects anti-Thy-1 response in mice.

Authors:  L J Quackenbush; W K Dowjat; M B Zaleski
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  The Ir-Thy-1 concept: continuing saga.

Authors:  M B Zaleski; L J Quackenbush; T J Gorzynski; J S Reichner
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  In vivo inhibition of anti-Thy-1 response by monoclonal antibody to the A molecules of the responder.

Authors:  M B Zaleski; T J Gorzynski; L J Quackenbush; W K Dowjat
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.